GCL
RVNC

Glazer Capital LLC’s Revance Therapeutics, Inc. RVNC Stock Holding History

Glazer Capital LLC’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,950,000
Closed -$5.93M – 214
2024
Q4 		$5.93M Buy
+1,950,000
New +$5.93M 0.4% 40
2024
Q3 		– Hold
0
– – – 156